Similar findings have been previously reported in the AD brain, considered as a positive control, showing an activation of TLR4 in both human AD diagnosed patients and AD animal models (Fiebich et al., 2018; Calvo-Rodriguez et al., 2020; Zhou et al., 2020). Here, TLR4 is linked to Alzheimer disease.